200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 5511-18-2
5511-18-2 | Adamantane-1-carboxamide
CAS No: 5511-18-2 Catalog No: AG003DWW MDL No:MFCD00077200
Product Description
Catalog Number:
AG003DWW
Chemical Name:
Adamantane-1-carboxamide
CAS Number:
5511-18-2
Molecular Formula:
C11H17NO
Molecular Weight:
179.2588
MDL Number:
MFCD00077200
IUPAC Name:
adamantane-1-carboxamide
InChI:
InChI=1S/C11H17NO/c12-10(13)11-4-7-1-8(5-11)3-9(2-7)6-11/h7-9H,1-6H2,(H2,12,13)
InChI Key:
CKBZJTAMRPPVSR-UHFFFAOYSA-N
SMILES:
NC(=O)C12CC3CC(C2)CC(C1)C3
Properties
Complexity:
218
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
179.131g/mol
Formal Charge:
0
Heavy Atom Count:
13
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
179.263g/mol
Monoisotopic Mass:
179.131g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
43.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2
Literature
| Title | Journal |
|---|---|
| Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors. | Bioorganic & medicinal chemistry 20121101 |
| Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors. | Methods in molecular biology (Clifton, N.J.) 20110101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents. | PloS one 20100101 |
| Selective P2X(7) receptor antagonists for chronic inflammation and pain. | Purinergic signalling 20090301 |
| Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors. | Bioorganic & medicinal chemistry letters 20070515 |
| Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors. | Bioorganic & medicinal chemistry letters 20061015 |
| New lamellar structure formed by an adamantyl derivative of cholic acid. | The journal of physical chemistry. B 20060720 |
| P2X(7) receptor: Death or life? | Purinergic signalling 20050901 |
| Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin. | Journal of medicinal chemistry 20050602 |
| Adamantylsulfanyl- and N-adamantylcarboxamido-derivatives of heterocycles and phenols: synthesis, crystal structure, tumor necrosis factor-alpha production-enhancing properties, and theoretical considerations. | Chemistry & biodiversity 20041001 |
| Crystal structures of dipeptides containing the Dmt-Tic pharmacophore. | Journal of medicinal chemistry 20021205 |
| Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. | Journal of medicinal chemistry 20020117 |
| Synthesis and modulation of cytokine production by two new adamantane substituted acyclic desmuramyldipeptide analogs. | Die Pharmazie 20010701 |
| Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist. | Brain research 20010525 |
| Capture of a single molecule in a nanocavity. | Science (New York, N.Y.) 20010126 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.